Simplex Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,600
| Closed | -$2K | – | 10398 |
|
|
2023
Q2 | $2K | Sell |
2,600
-29,800
| -92% | -$210K | ﹤0.01% | 8544 |
|
|
2023
Q1 | $136K | Buy |
32,400
+22,600
| +231% | +$117K | ﹤0.01% | 4800 |
|
|
2022
Q4 | $58K | Sell |
9,800
-8,300
| -46% | -$45.3K | ﹤0.01% | 5695 |
|
|
2022
Q3 | $105K | Sell |
18,100
-9,600
| -35% | -$59.8K | ﹤0.01% | 5461 |
|
|
2022
Q2 | $165K | Sell |
27,700
-30,000
| -52% | -$154K | ﹤0.01% | 4872 |
|
|
2022
Q1 | $269K | Buy |
57,700
+57,100
| +9,517% | +$170K | ﹤0.01% | 4708 |
|
|
2021
Q4 | $1K | Sell |
600
-26,300
| -98% | -$64.3K | ﹤0.01% | 10339 |
|
|
2021
Q3 | $69K | Hold |
26,900
| – | – | ﹤0.01% | 7112 |
|
|
2021
Q2 | $67K | Buy |
26,900
+26,669
| +11,545% | +$63.9K | ﹤0.01% | 7280 |
|
|
2021
Q1 | $67K | Buy |
+231
| New | +$754 | ﹤0.01% | 6266 |
|
|
2020
Q4 | – | Sell |
-51
| Closed | -$10K | – | 9542 |
|
|
2020
Q3 | $10K | Buy |
+51
| New | +$65 | ﹤0.01% | 6823 |
|
|
2019
Q3 | – | Sell |
-47
| Closed | -$4K | – | 8350 |
|
|
2019
Q2 | $4K | Sell |
47
-36
| -43% | -$33 | ﹤0.01% | 6605 |
|
|
2019
Q1 | $8K | Buy |
+83
| New | +$87 | ﹤0.01% | 6310 |
|
|
2018
Q4 | – | Sell |
-98
| Closed | -$21K | – | 8502 |
|
|
2018
Q3 | $21K | Buy |
+98
| New | +$243 | ﹤0.01% | 5938 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$2K | – | 7057 |
|
|
2016
Q1 | $2K | Buy |
+1
| New | +$8 | ﹤0.01% | 4956 |
|
|
2015
Q2 | – | Sell |
-15
| Closed | -$4K | – | 6519 |
|
|
2015
Q1 | $4K | Buy |
15
+14
| +1,400% | +$315 | ﹤0.01% | 3782 |
|
|
2014
Q4 | $1K | Buy |
+1
| New | +$23 | ﹤0.01% | 4553 |
|
Simplex Trading's CTIC Position: Q2 2023 in Review
Simplex Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 14,801 shares — an estimated $104K sold.
Simplex Trading first reported a position in CTIC in Q1 2015 and held it in 18 quarters. The position peaked at $740K in Q1 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Simplex Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 14,801 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $104K.
- Simplex Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 18 quarters.
- Simplex Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $740K in Q1 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.